导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.64% | 392/1050 |
| 近一周 | -2.21% | 497/1104 |
| 近一月 | -4.69% | 576/1102 |
| 近一季 | -8.56% | 608/1092 |
| 近半年 | -0.49% | 433/1070 |
| 近一年 | 7.95% | 390/1018 |
| 近两年 | 60.43% | 425/926 |
| 近三年 | 37.36% | 337/834 |
| 成立以来 | 342.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.42% 452/1070 |
18.03% 408/1101 |
- - |
- - |
| 2025 | 27.23% 528/1065 |
- 796/1014 |
2.48% 469/1038 |
24.50% 454/1050 |
-0.28% 472/1065 |
| 2024 | 9.72% 296/1011 |
2.66% 178/960 |
-2.59% 471/983 |
13.09% 373/991 |
-2.98% 535/1011 |
| 2023 | -11.07% 369/952 |
1.56% 537/880 |
-3.12% 386/895 |
-3.93% 242/915 |
-5.91% 600/952 |
| 2022 | -17.30% 231/867 |
-15.63% 289/773 |
7.68% 364/806 |
-10.86% 294/845 |
2.12% 319/867 |
| 2021 | 10.42% 243/740 |
1.37% 103/580 |
10.59% 342/659 |
-4.55% 333/704 |
3.20% 295/740 |
| 2020 | 52.24% 230/554 |
-5.13% 294/419 |
22.13% 249/466 |
14.80% 144/517 |
14.46% 215/554 |
| 2019 | 44.54% 188/410 |
25.53% 666/1149 |
1.30% 224/1231 |
4.28% 214/390 |
9.00% 192/410 |
| 2018 | -22.41% 104/349 |
- - |
- - |
- - |
-11.14% 409/1080 |
| 2017 | 25.53% 60/285 |
- - |
- - |
- - |
- - |
| 2016 | -7.07% 55/205 |
- - |
- - |
- - |
- - |
| 2015 | 31.73% 47/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实研究阿尔法股票A VS. 东吴新产业精选股票A(580008) |